7/11/2025BeOne's Tevimbra Wins EU Green Light for First-Line Nasopharyngeal Can...

7/11/2025China's NHSA Unveils 2025 Drug Directory Revisions and Submission Guid...

7/11/2025China Issues 2nd Batch of Rare Disease Clinical Guidelines to Strength...

7/10/2025Henlius Wins Global Regulatory Clearance to Launch Phase 2 Trial of PD...

7/10/2025China Approves Three New Drugs for Cancer, ED and Pediatric Sleep Diso...

7/10/2025Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery...

7/10/2025China's Biopharma Licensing Deals Surge in H1 2025, Fueled by Cross-Bo...

7/9/2025Simcere Advances Rademikibart with NDA Submission for Atopic Dermatiti...

7/9/2025China Struggles to Maintain Grip on India's Bulk Drug Market Amid Risi...

7/9/2025Hansoh Pharma Launches Phase 1 Trial of HS-20093 with Adebrelimab in F...

7/9/2025NKCellTech Secures Nearly CNY100M in Series A+++ Financing

More>>

7/10/2025China's Rising Biotechnology Sector: Friend or Foe? (EGGI)

7/8/2025As Chinese-developed Drugs Draw U.S. Interest, A Regulatory Chill Thre...

7/2/2025FDA's Crackdown and China's Dealmaking: Warning Signs or Business as U...

7/2/2025Medical Advances Soar With APAC's Clinical Trial Growth (BioSpectrum)

7/1/2025Tracking the Crossroads of Policy, Innovation, and Global Biotech Inve...

7/1/2025BeOne Launches Phase III Trial Comparing Subcutaneous and Intravenous ...

7/1/2025China Launches Landmark Measures to Boost Innovative Drug Industry, Se...

6/27/2025Analyzing Key Trends in China's Patent-Linkage System and Their Impact...

6/27/2025Fresh Antitrust Guidelines to Address Pharmaceutical Monopoly Issues i...

6/25/2025Breaking the Boundaries: A New Map of Physician Behavior in China's Di...

6/19/2025Structuring Cross Border China Biotech 'NewCo' Transactions (Life Scie...

More>>